You are here:

MS in the media - 9 March 2018

Published on

3 - 9 March 2018

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Zinbryta withdrawn due to safety fears

The makers of Zinbryta (daclizumab), a disease modifying drug for relapsing MS, have withdrawn the medication due to cases of serious brain inflammation (encephalitis).  No new research is planned.

Source: Biogen press release
Source: MedPage Today
Source: European Medicinces Agency (EMA)

MS Trust link: Zinbryta (daclizumab)

Sunshine exposure reduces MS risk

Canadian research has found that growing up and spending time outdoors in a sunnier climate with exposure to UV-B light led to a reduction in risk of developing MS.  A smaller proportion of people with MS grew up in sunnier areas than in a less sunny climate.

Source: Science Daily
Source: Medical News Today
Source: Daily Mail

MS Trust link: Vitamin D

Unsuccessful trial of PPMS drug

In a trial, Raxone (idebenone), a potential treatment for primary progressive MS was no more effective than placebo according to the manufacturer.

Source: Pharma Times

MS Trust link: Drugs in development

Paralympian with MS

Hugh Nibloe, who has MS, will be part of the British curling team at the Winter Paralympics, which start on Friday (9 March).

Source: Yahoo
Source: BBC

MS Trust link: Personal stories of life with MS

Print this page